 |
|
Vancomycin in Severe Staphylococcal Infections
DONALD B. LOURIA, M.D.;
THERESA KAMINSKI, B.A.;
JOSEPH BUCHMAN, M.D.
Arch Intern Med. 1961;107(2):225-240.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
The therapy of severe staphylococcal infections caused by microorganisms resistant to penicillin is currently unsatisfactory.
In 1955, a new antimicrobial agent, vancomycin, was isolated from strains of Streptomyces orientalis. This antibiotic was markedly effective in vitro against Gram-positive microorganisms, including staphylococci which were resistant to penicillin and other antistaphylococcal antimicrobials commonly in use.1,2
Studies by several authors3-7 have indicated that vancomycin is beneficial in severe staphylococcal disease in man. The effects of vancomycin therapy in 8 patients who had overwhelming staphylococcal infection are reported in the present studies. Complete clinical recovery and apparent eradication of the infection was achieved in 5 of the 8 patients. Marked improvement occurred in one patient, but the microorganism was not eradicated. Two patients were considered to be therapeutic failures.
These cases are reported below in detail to permit clear evaluation of the capabilities of this new and effective antistaphylococcal agent. Special attention
. . . [Full Text PDF of this Article]
Author Affiliations
NEW YORK
From the Infectious Disease Laboratory, Second (Cornell) Medical Division, the Fourth (The New York University) Medical Division, Bellevue Hospital, and Cornell University Medical College, New York.
Footnotes
Submitted for publication April 15, 1960.
This work was supported in part by grants from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md. (E-2659), The Health Research Council of New York City, and The New York Trudeau Society.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
